Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture

A series of novel amphiphilic macromolecules composed of alkyl chains as the hydrophobic block and poly(ethylene glycol) as the hydrophilic block were designed to inhibit highly oxidized low density lipoprotein (hoxLDL) uptake by synthesizing macromolecules with negatively charged moieties (ie, carboxylic acids) located in the two different blocks. The macromolecules have molecular weights around 5,500 g/mol, form micelles in aqueous solution with an average size of 20–35 nm, and display critical micelle concentration values as low as 10−7 M. Their charge densities and hydrodynamic size in physiological buffer solutions correlated with the hydrophobic/hydrophilic block location and quantity of the carboxylate groups. Generally, carboxylate groups located in the hydrophobic block destabilize micelle formation more than carboxylate groups in the hydrophilic block. Although all amphiphilic macromolecules inhibited unregulated uptake of hoxLDL by macrophages, inhibition efficiency was influenced by the quantity and location of the negatively charged-carboxylate on the macromolecules. Notably, negative charge is not the sole factor in reducing hoxLDL uptake. The combination of smaller size, micellar stability and charge density is critical for inhibiting hoxLDL uptake by macrophages.

[1]  J. Benoit,et al.  Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. , 2006, Journal of biomedical materials research. Part A.

[2]  K. Uhrich,et al.  Novel amphiphilic macromolecules and their in vitro characterization as stabilized micellar drug delivery systems. , 2006, Journal of colloid and interface science.

[3]  P. Moghe,et al.  Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages. , 2006, Biomacromolecules.

[4]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[5]  P. Moghe,et al.  Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL. , 2006, Biomacromolecules.

[6]  S. Ramakrishna,et al.  Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. , 2005, Biomaterials.

[7]  S. Ramakrishna,et al.  Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. , 2005, Tissue engineering.

[8]  T. Malinski Understanding nitric oxide physiology in the heart: a nanomedical approach. , 2005, The American journal of cardiology.

[9]  Wei He,et al.  Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell Orientation. , 2005, Tissue engineering.

[10]  J. Meng,et al.  Improving the blood compatibility of polyurethane using carbon nanotubes as fillers and its implications to cardiovascular surgery. , 2005, Journal of biomedical materials research. Part A.

[11]  G. Velasco-Loyden,et al.  Control of scavenger receptor-mediated endocytosis by novel ligands of different length , 2005, Molecular and Cellular Biochemistry.

[12]  Stephan Marsch,et al.  Cell targeting by a generic receptor-targeted polymer nanocontainer platform. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[13]  F. Nakajima,et al.  2,4‐Bis(octadecanoylamino)benzenesulfonic Acid Sodium Salt as a Novel Scavenger Receptor Inhibitor with Low Molecular Weight. , 2004 .

[14]  Isabelle Raynal,et al.  Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10 , 2004, Investigative radiology.

[15]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[16]  S. Volinia,et al.  Nanotechnologies and microchips in genetic diseases. , 2003, Journal of nephrology.

[17]  G. Bondjers,et al.  The extracellular matrix on atherogenesis and diabetes-associated vascular disease. , 2002, Atherosclerosis. Supplements.

[18]  J. Moses,et al.  Glycosaminoglycan-lipoprotein interaction , 2001, Glycoconjugate Journal.

[19]  S. Gordon,et al.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. , 2001, The Journal of clinical investigation.

[20]  A. Chait,et al.  Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices. , 2001, Journal of lipid research.

[21]  H. Jo,et al.  Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. , 2000, Free radical biology & medicine.

[22]  A. Annila,et al.  Oxidation of Low Density Lipoprotein Particles Decreases Their Ability to Bind to Human Aortic Proteoglycans , 1997, The Journal of Biological Chemistry.

[23]  Daniel Steinberg,et al.  Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.

[24]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[25]  M. Krieger,et al.  Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. , 1993, The Journal of biological chemistry.

[26]  M. Traber,et al.  Receptor activities for low-density lipoprotein and acetylated low- density lipoprotein in a mouse macrophage cell line (IC21) and in human monocyte-derived macrophages , 1981, The Journal of experimental medicine.

[27]  Y. Kim,et al.  Thrombogenicity and blood coagulation of a microcatheter prepared from carbon nanotube-nylon-based composite. , 2005, Nano letters.

[28]  M. Barch,et al.  Polymeric Micelles Based on Amphiphilic Scorpion-like Macromolecules: Novel Carriers for Water-Insoluble Drugs , 2004, Pharmaceutical Research.

[29]  K. Uhrich,et al.  Amphiphilic Scorpion-like Macromolecules: Design, Synthesis, and Characterization , 2004 .

[30]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.